Zi-Han Gao Selected Research

Ketoglutaric Acids (Ketoglutaric Acid)

11/2019

Evidence for the Capability of Roxadustat (FG-4592), an Oral HIF Prolyl-Hydroxylase Inhibitor, to Perturb Membrane Ionic Currents: An Unidentified yet Important Action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zi-Han Gao Research Topics

Disease

3	Pituitary Neoplasms (Pituitary Adenoma) 01/2020 - 11/2019
1	Fibrosis (Cirrhosis) 03/2020
1	Coronavirus Infections 01/2020
1	Hypoxia (Hypoxemia) 11/2019
1	Necrosis 07/2019
1	Neoplasms (Cancer) 07/2019
1	Inflammation (Inflammations) 07/2019
1	Unstable Angina 12/2014

Drug/Important Bio-Agent (IBA)

1	remdesivirIBA 01/2020
1	GAL021IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2019
1	roxadustatIBA 11/2019
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 11/2019
1	CationsIBA 11/2019
1	ImmunosorbentsIBA 07/2019
1	EnzymesIBA 07/2019
1	saikosaponin DIBA 07/2019

Therapy/Procedure

1	Transplantation 03/2020
1	Percutaneous Coronary Intervention 12/2014